Narus Financial Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
1,024
+72
+8% +$16.8K 0.07% 149
2026
Q1
$233K Buy
+952
New +$222K 0.06% 149
2023
Q1
Sell
-1,381
Closed -$244K 117
2022
Q4
$244K Sell
1,381
-108
-7% -$18.6K 0.14% 102
2022
Q3
$243K Buy
1,489
+8
+0.5% +$1.35K 0.15% 94
2022
Q2
$263K Buy
1,481
+17
+1% +$3.03K 0.17% 82
2022
Q1
$259K Buy
+1,464
New +$249K 0.15% 94
2021
Q1
$252K Buy
+1,536
New +$249K 0.15% 85

Other funds holding JNJ

Narus Financial Partners's JNJ Position: Q2 2026 in Review

Narus Financial Partners increased its Johnson & Johnson (JNJ) stake by 7.6% in Q2 2026, buying an estimated $16.8K and bringing the position to 1,024 shares worth $260K. The position accounts for 0.07% of the portfolio, ranked #149.

Narus Financial Partners first reported a position in JNJ in Q1 2021 and has held it in 7 quarters since. The position peaked at $263K in Q2 2022. 2,417 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Narus Financial Partners held 1,024 shares of Johnson & Johnson worth $260K as of Q2 2026.
  • Narus Financial Partners bought 72 Johnson & Johnson shares in Q2 2026, an estimated $16.8K.
  • Johnson & Johnson made up 0.07% of Narus Financial Partners's portfolio in Q2 2026, its #149 holding.
  • Narus Financial Partners first reported a position in Johnson & Johnson in Q1 2021 and has held it in 7 quarters since.
  • Narus Financial Partners's Johnson & Johnson position peaked at $263K in Q2 2022.
  • 2,417 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Narus Financial Partners's 13F filing for Q2 2026, filed 31 Jul 2026.